Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics

A. Hořínek, M. Korabečná, A. Panczak, Z. Ulčová-Gallová, K. Nouzová, P. Calda, M. Hančárová

. 2008 ; 24 (1) : 15-21.

Jazyk angličtina Země Švýcarsko

Typ dokumentu srovnávací studie, hodnotící studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc11003773
E-zdroje Online Plný text

NLK Karger Journals od 1998-01-01 do 2009
ProQuest Central od 1998-01-01 do 2015-12-31
Health & Medicine (ProQuest) od 1998-01-01 do 2015-12-31

OBJECTIVE: To analyze methodological influences and characterize the concentrations of cell-free fetal DNA (cffDNA) circulating in maternal plasma at different gestational ages in physiological pregnancies. METHODS: We investigated 238 independent samples from single male-bearing pregnancies of different gestation age. In the other 50 pregnancies, the samples were collected three times during pregnancy (at all trimesters) to evaluate the kinetics of cffDNA. The manual and automated DNA extraction methods (Roche) were compared. cffDNA was amplified using real-time PCR method and Y-specific sequences SRY and DYS14. Total cell-free DNA circulating in maternal plasma was determined by the use of the GADPH sequence. RESULTS: The elevation in the concentration of cffDNA during pregnancy with the highest value in the third trimester was observed independently on the DNA extraction method and on the Y-specific amplified sequence. The same is documented for the percentage of fetal DNA in total cell-free DNA in maternal plasma. It increases also in successive trimesters (8.3, 10.7 and 23.2%). CONCLUSIONS: We discuss methodological problems and describe statistical parameters of cffDNA concentrations in maternal plasma during pregnancy as the basic information for comparison with pregnancies having a pathological outcome. Copyright 2008 S. Karger AG, Basel

Citace poskytuje Crossref.org

000      
01758naa 2200433 a 4500
001      
bmc11003773
003      
CZ-PrNML
005      
20121130120126.0
008      
110302s2008 sz e eng||
009      
AR
024    __
$a 10.1159/000132400 $2 doi
035    __
$a (PubMed)18504375
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hořínek, Aleš, $d 1961- $7 xx0061416
245    10
$a Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics / $c A. Hořínek, M. Korabečná, A. Panczak, Z. Ulčová-Gallová, K. Nouzová, P. Calda, M. Hančárová
314    __
$a 3rd Medical Department, Charles University, Pilsen, Czech Republic.
520    9_
$a OBJECTIVE: To analyze methodological influences and characterize the concentrations of cell-free fetal DNA (cffDNA) circulating in maternal plasma at different gestational ages in physiological pregnancies. METHODS: We investigated 238 independent samples from single male-bearing pregnancies of different gestation age. In the other 50 pregnancies, the samples were collected three times during pregnancy (at all trimesters) to evaluate the kinetics of cffDNA. The manual and automated DNA extraction methods (Roche) were compared. cffDNA was amplified using real-time PCR method and Y-specific sequences SRY and DYS14. Total cell-free DNA circulating in maternal plasma was determined by the use of the GADPH sequence. RESULTS: The elevation in the concentration of cffDNA during pregnancy with the highest value in the third trimester was observed independently on the DNA extraction method and on the Y-specific amplified sequence. The same is documented for the percentage of fetal DNA in total cell-free DNA in maternal plasma. It increases also in successive trimesters (8.3, 10.7 and 23.2%). CONCLUSIONS: We discuss methodological problems and describe statistical parameters of cffDNA concentrations in maternal plasma during pregnancy as the basic information for comparison with pregnancies having a pathological outcome. Copyright 2008 S. Karger AG, Basel
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a biochemická analýza krve $x metody $7 D001774
650    _2
$a DNA $x krev $7 D004247
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a plod $7 D005333
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a maternofetální výměna látek $7 D008431
650    _2
$a těhotenství $x krev $7 D011247
650    _2
$a první trimestr těhotenství $x krev $7 D011261
650    _2
$a druhý trimestr těhotenství $x krev $7 D011262
650    _2
$a třetí trimestr těhotenství $x krev $7 D011263
650    _2
$a financování organizované $7 D005381
655    _2
$a srovnávací studie $7 D003160
655    _2
$a hodnotící studie $7 D023362
700    1_
$a Korabečná, Marie, $d 1961- $7 xx0070811
700    1_
$a Panczak, Aleš. $7 ja20020046920
700    1_
$a Ulčová-Gallová, Zdenka, $d 1954- $7 jn20000402453
700    1_
$a Nouzová, Kamila $7 xx0079583
700    1_
$a Calda, Pavel, $d 1957- $7 mzk2006323882
700    1_
$a Hančárová, Miroslava. $7 xx0275406
773    0_
$t Fetal Diagnosis & Therapy $g Roč. 24, č. 1 (2008), s. 15-21 $w MED00001797
910    __
$a ABA008 $b x $y 7
990    __
$a 20110413121953 $b ABA008
991    __
$a 20121130120155 $b ABA008
999    __
$a ok $b bmc $g 831142 $s 695796
BAS    __
$a 3
BMC    __
$a 2008 $b 24 $c 1 $d 15-21 $m Fetal diagnosis and therapy $n Fetal Diagn Ther $x MED00001797
LZP    __
$a 2011-3B/vtme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé